Pembrolizumab vs Semaglutide
Pembrolizumab vs Semaglutide: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Semaglutide.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Semaglutide: GLP-1 receptor agonist with enhanced albumin binding for extended action.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Semaglutide — 7 days.
Chemical Properties
Type: Pembrolizumab — Antibody; Semaglutide — Protein.